154 related articles for article (PubMed ID: 11378658)
1. P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.
Varki A; Varki NM
Braz J Med Biol Res; 2001 Jun; 34(6):711-7. PubMed ID: 11378658
[TBL] [Abstract][Full Text] [Related]
2. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
Varki NM; Varki A
Semin Thromb Hemost; 2002 Feb; 28(1):53-66. PubMed ID: 11885026
[TBL] [Abstract][Full Text] [Related]
3. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.
Borsig L; Wong R; Feramisco J; Nadeau DR; Varki NM; Varki A
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3352-7. PubMed ID: 11248082
[TBL] [Abstract][Full Text] [Related]
4. Selectively desulfated heparin inhibits P-selectin-mediated adhesion of human melanoma cells.
Wei M; Gao Y; Tian M; Li N; Hao S; Zeng X
Cancer Lett; 2005 Nov; 229(1):123-6. PubMed ID: 16157224
[TBL] [Abstract][Full Text] [Related]
5. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
6. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
Borsig L
Semin Thromb Hemost; 2007 Jul; 33(5):540-6. PubMed ID: 17629852
[TBL] [Abstract][Full Text] [Related]
7. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
Stevenson JL; Varki A; Borsig L
Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703
[TBL] [Abstract][Full Text] [Related]
8. Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment.
Gomes AM; Kozlowski EO; Borsig L; Teixeira FC; Vlodavsky I; Pavão MS
Glycobiology; 2015 Apr; 25(4):386-93. PubMed ID: 25367817
[TBL] [Abstract][Full Text] [Related]
9. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.
Kim YJ; Borsig L; Han HL; Varki NM; Varki A
Am J Pathol; 1999 Aug; 155(2):461-72. PubMed ID: 10433939
[TBL] [Abstract][Full Text] [Related]
10. A low-anticoagulant heparin suppresses metastatic dissemination through the inhibition of tumor cell-platelets association.
Motta JM; Micheli KVA; Roberto-Fernandes C; Hermsdorff-Brandt M; Guedes AL; Frattani FS; Mourão PAS; Pereira MS
Biomed Pharmacother; 2024 Feb; 171():116108. PubMed ID: 38218079
[TBL] [Abstract][Full Text] [Related]
11. P-selectin deficiency attenuates tumor growth and metastasis.
Kim YJ; Borsig L; Varki NM; Varki A
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9325-30. PubMed ID: 9689079
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.
Borsig L; Wong R; Hynes RO; Varki NM; Varki A
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2193-8. PubMed ID: 11854515
[TBL] [Abstract][Full Text] [Related]
13. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.
Wahrenbrock M; Borsig L; Le D; Varki N; Varki A
J Clin Invest; 2003 Sep; 112(6):853-62. PubMed ID: 12975470
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.
Shao B; Wahrenbrock MG; Yao L; David T; Coughlin SR; Xia L; Varki A; McEver RP
Blood; 2011 Oct; 118(15):4015-23. PubMed ID: 21860019
[TBL] [Abstract][Full Text] [Related]
15. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.
Ludwig RJ; Boehme B; Podda M; Henschler R; Jager E; Tandi C; Boehncke WH; Zollner TM; Kaufmann R; Gille J
Cancer Res; 2004 Apr; 64(8):2743-50. PubMed ID: 15087389
[TBL] [Abstract][Full Text] [Related]
16. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment.
Borsig L; Wang L; Cavalcante MC; Cardilo-Reis L; Ferreira PL; Mourão PA; Esko JD; Pavão MS
J Biol Chem; 2007 May; 282(20):14984-91. PubMed ID: 17371880
[TBL] [Abstract][Full Text] [Related]
17. Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
Zhang C; Liu Y; Gao Y; Shen J; Zheng S; Wei M; Zeng X
Int J Cancer; 2009 Nov; 125(9):2058-65. PubMed ID: 19598263
[TBL] [Abstract][Full Text] [Related]
18. Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin.
Li Y; Luo JY; Cui HF; Zheng L; Du SS
Biomed Pharmacother; 2010 Dec; 64(10):654-8. PubMed ID: 20970300
[TBL] [Abstract][Full Text] [Related]
19. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X
J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
Fritzsche J; Simonis D; Bendas G
Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
